Subscribe to amaxa eNews
Subscribe to RSS Feeds
Lonza Group (SWX:Lonn) announces that it has completed the acquisiton of amaxa as of 2 July 2008. This deal significantly strengthens the Cell Discovery business of Lonza by complementing and expanding the existing portfolio.
New - High Throughput Nucleofection of Human Stem Cell Line H9
With the new 
Human Stem Cell (H9) 96-well Nucleofector Kit amaxa broadened its product portfolio for Human Stem Cells. The kit allows high performance Nucleofection on H9 cells in a 96-well format. Read more ...
New: Basic 96-well Nucleofector Kits for Primary Fibroblasts
The Basic 96-well Nucleofector Kits for Primary Mammalian Fibroblasts now allow high throughput transfection using your fibroblast cell type of interest. Read more...
New 96-well Shuttle Movie
Watch the new
96-well Shuttle Movie
featuring the whole nucleofection process on the 96-well Shuttle.
